HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Viktrup Selected Research

Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

1/2019Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study.
1/2017Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies.
10/2015Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action.
6/2015Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo.
5/2015Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia – integrated data from 1,499 study participants.
4/2015Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analyses of data pooled from three randomized, double-blind, placebo-controlled studies.
1/2015Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
10/2014Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.
7/2014Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea.
4/2014Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Viktrup Research Topics

Disease

32Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2019 - 10/2008
31Lower Urinary Tract Symptoms
01/2019 - 10/2008
18Osteoarthritis
03/2022 - 01/2019
16Pain (Aches)
01/2022 - 10/2018
16Erectile Dysfunction
01/2019 - 10/2008
9Stress Urinary Incontinence
02/2010 - 01/2004
6Hip Osteoarthritis (Coxarthrosis)
03/2022 - 01/2019
5Major Depressive Disorder (Major Depressive Disorders)
01/2007 - 01/2004
4Low Back Pain (Lumbago)
04/2022 - 10/2019
4Knee Osteoarthritis
01/2022 - 01/2020
3Chronic Pain
01/2022 - 10/2019
3Arthralgia (Joint Pain)
01/2021 - 01/2019
3Urinary Incontinence
06/2008 - 01/2005
2Neuralgia (Stump Neuralgia)
01/2007 - 11/2005
1Radiculopathy (Radiculopathy, Cervical)
03/2022
1Peripheral Nervous System Diseases (PNS Diseases)
03/2022
1Polyneuropathies (Polyneuropathy)
03/2022
1Mononeuropathies (Mononeuritis Multiplex)
03/2022
1Hypesthesia (Numbness)
01/2022
1Paresthesia (Dysesthesia)
01/2022
1Bradycardia
01/2022
1Orthostatic Hypotension (Postural Hypotension)
01/2022
1Nocturia
10/2014
1Polyuria
10/2014
1Hypertension (High Blood Pressure)
09/2013
1Cardiovascular Diseases (Cardiovascular Disease)
09/2013
1Back Pain (Backache)
11/2011
1Headache (Headaches)
11/2011
1Ischemia
03/2011
1Hyperhidrosis
06/2008
1Fatigue
06/2008
1Constipation
06/2008
1Lung Diseases (Lung Disease)
07/2007
1Obesity
07/2007
1Diabetes Mellitus
07/2007
1Fibromyalgia (Fibrositis)
01/2007
1Anxiety Disorders (Anxiety Disorder)
01/2007
1Bipolar Disorder (Manic Depressive Psychosis)
01/2004
1Mania (Manias)
01/2004
1Urinary Retention
01/2004

Drug/Important Bio-Agent (IBA)

32Tadalafil (Cialis)FDA Link
01/2019 - 10/2008
17tanezumabIBA
04/2022 - 10/2018
10Duloxetine Hydrochloride (Cymbalta)FDA Link
02/2010 - 01/2004
8Phosphodiesterase 5 InhibitorsIBA
10/2015 - 10/2008
7Nerve Growth Factor (NGF)IBA
01/2022 - 10/2018
5Prostaglandins AIBA
01/2022 - 01/2019
5Analgesics (Analgesic Drugs)IBA
11/2021 - 01/2019
5Tamsulosin (Flomax)FDA LinkGeneric
01/2019 - 09/2011
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2022 - 01/2020
4Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2005 - 01/2004
4Serotonin (5 Hydroxytryptamine)IBA
11/2005 - 01/2004
3Finasteride (Propecia)FDA LinkGeneric
06/2015 - 03/2014
2Pharmaceutical PreparationsIBA
01/2022 - 01/2004
2Opioid Analgesics (Opioids)IBA
11/2021 - 01/2020
2Acetaminophen (Paracetamol)FDA LinkGeneric
11/2021 - 01/2020
2AntibodiesIBA
11/2021 - 10/2019
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
10/2015 - 09/2013
1Celecoxib (Celebrex)FDA Link
04/2022
1Guanosine Monophosphate (5' Guanylic Acid)IBA
03/2011
1Phosphotransferases (Kinase)IBA
03/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2011
1Antidepressive Agents (Antidepressants)IBA
01/2004

Therapy/Procedure

8Therapeutics
07/2021 - 02/2010
2Drug Therapy (Chemotherapy)
07/2021 - 01/2004
2Replacement Arthroplasty
01/2021 - 01/2019
1Combined Modality Therapy
01/2020
1Institutionalization (Institutionalized Persons)
01/2005